Assessing Effectiveness of a Diabetes Navigator in Increasing Progression of Advanced Diabetes Technologies

NAActive, not recruitingINTERVENTIONAL
Enrollment

148

Participants

Timeline

Start Date

February 13, 2024

Primary Completion Date

August 26, 2025

Study Completion Date

December 1, 2025

Conditions
Diabetes Mellitus, Type 1
Interventions
BEHAVIORAL

Diabetes Navigator

Participants in the Diabetes Navigator (DN) arm will receive support from a trained navigator to help them improve progression (improving use/optimization) in use of advanced diabetes technology. The Diabetes Navigator will engage with participants immediately after randomization, throughout the duration of study, using a predefined toolkit, educational resources and interventions to assist them in optimizing use of advanced diabetes technology.

Trial Locations (1)

21205

Johns Hopkins University School of Medicine, Baltimore

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Johns Hopkins University

OTHER

NCT06229236 - Assessing Effectiveness of a Diabetes Navigator in Increasing Progression of Advanced Diabetes Technologies | Biotech Hunter | Biotech Hunter